Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 59

    1.

    Consensus report of the coalition for clinical research-self-monitoring of blood glucose.

    Klonoff DC, Bergenstal R, Blonde L, Boren SA, Church TS, Gaffaney J, Jovanovic L, Kendall DM, Kollman C, Kovatchev BP, Leippert C, Ddg D, Owens DR, Polonsky WH, Reach G, Renard E, Riddell MC, Rubin RR, Schnell O, Siminiero LM, Vigersky RA, Wilson DM, Wollitzer AO.

    J Diabetes Sci Technol. 2008 Nov;2(6):1030-53.PMID: 19885292 [PubMed - in process]Free article

    2.

    A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project.

    Leite SA, Anderson RL, Kendall DM, Monk AM, Bergenstal RM.

    Diabetol Metab Syndr. 2009 Sep 16;1(1):5.PMID: 19825200 [PubMed - in process]Related articlesFree article

    3.

    Low cardiorespiratory fitness in people at risk for type 2 diabetes: early marker for insulin resistance.

    Leite SA, Monk AM, Upham PA, Bergenstal RM.

    Diabetol Metab Syndr. 2009 Sep 21;1(1):8.PMID: 19825145 [PubMed - in process]Related articlesFree article

    4.

    Does availability of AIR insulin increase insulin use and improve glycemic control in patients with type 2 diabetes?

    Bergenstal RM, Freemantle N, Leyk M, Cutler GB Jr, Hayes RP, Muchmore DB.

    Diabetes Technol Ther. 2009 Sep;11 Suppl 2:S45-52.PMID: 19772448 [PubMed - in process]Related articles

    5.

    Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use.

    Kendall DM, Cuddihy RM, Bergenstal RM.

    Eur J Intern Med. 2009 Jul;20 Suppl 2:S329-39. Epub 2009 Jun 24. Review.PMID: 19580952 [PubMed - indexed for MEDLINE]Related articles

    6.

    Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use.

    Kendall DM, Cuddihy RM, Bergenstal RM.

    Am J Med. 2009 Jun;122(6 Suppl):S37-50. Review.PMID: 19464427 [PubMed - indexed for MEDLINE]Related articles

    7.

    Diurnal glucose patterns of exenatide once weekly: a 1-year study using continuous glucose monitoring with ambulatory glucose profile analysis.

    Mazze R, Strock E, Morgan B, Wesley D, Bergenstal R, Cuddihy R.

    Endocr Pract. 2009 Jul-Aug;15(4):326-34.PMID: 19454385 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.

    Bergenstal R, Lewin A, Bailey T, Chang D, Gylvin T, Roberts V; NovoLog Mix-vs.-Exenatide Study Group.

    Curr Med Res Opin. 2009 Jan;25(1):65-75.PMID: 19210140 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.

    Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

    J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. Review. No abstract available. PMID: 19147051 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.

    Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

    Circulation. 2009 Jan 20;119(2):351-7. Epub 2008 Dec 17. Review. No abstract available. Erratum in: Circulation. 2009 Jun 30;119(25):e605. PMID: 19095622 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.

    Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American College of Cardiology Foundation; American Heart Association.

    Diabetes Care. 2009 Jan;32(1):187-92. Epub 2008 Dec 17. No abstract available. PMID: 19092168 [PubMed - in process]Related articlesFree article

    13.

    Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial.

    Shikora SA, Bergenstal R, Bessler M, Brody F, Foster G, Frank A, Gold M, Klein S, Kushner R, Sarwer DB.

    Surg Obes Relat Dis. 2009 Jan-Feb;5(1):31-7. Epub 2008 Oct 1.PMID: 19071066 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM).

    Hirsch IB, Armstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, Peters A, Wolpert H.

    Diabetes Technol Ther. 2008 Aug;10(4):232-44; quiz 245-6. Review.PMID: 18699743 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents.

    Rosenstock J, Bergenstal R, Defronzo RA, Hirsch IB, Klonoff D, Boss AH, Kramer D, Petrucci R, Yu W, Levy B; 0008 Study Group.

    Diabetes Care. 2008 Nov;31(11):2177-82. Epub 2008 Aug 4.PMID: 18678610 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial.

    Liebl A, Prager R, Binz K, Kaiser M, Bergenstal R, Gallwitz B; PREFER Study Group.

    Diabetes Obes Metab. 2009 Jan;11(1):45-52. Epub 2008 Jul 17.PMID: 18643839 [PubMed - indexed for MEDLINE]Related articles

    17.

    Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis.

    Mazze RS, Strock E, Wesley D, Borgman S, Morgan B, Bergenstal R, Cuddihy R.

    Diabetes Technol Ther. 2008 Jun;10(3):149-59.PMID: 18473688 [PubMed - indexed for MEDLINE]Related articles

    18.

    A new look at screening and diagnosing diabetes mellitus.

    Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB.

    J Clin Endocrinol Metab. 2008 Jul;93(7):2447-53. Epub 2008 May 6. Review.PMID: 18460560 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.

    Bergenstal RM, Johnson M, Powers MA, Wynne A, Vlajnic A, Hollander P, Rendell M.

    Diabetes Care. 2008 Jul;31(7):1305-10. Epub 2008 Mar 25.PMID: 18364392 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Integrated practice units are bridges, not 'archipelagoes'.

    Bergenstal RM.

    Health Aff (Millwood). 2008 Mar-Apr;27(2):592; author reply 592-3. No abstract available. PMID: 18332532 [PubMed - indexed for MEDLINE]Related articles

    21.

    Effects of exenatide versus insulin analogues on weight change in subjects with type 2 diabetes: a pooled post-hoc analysis.

    Glass LC, Qu Y, Lenox S, Kim D, Gates JR, Brodows R, Trautmann M, Bergenstal RM.

    Curr Med Res Opin. 2008 Mar;24(3):639-44. Epub 2008 Jan 23.PMID: 18218179 [PubMed - indexed for MEDLINE]Related articles

    22.

    Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

    Bonds DE, Kurashige EM, Bergenstal R, Brillon D, Domanski M, Felicetta JV, Fonseca VA, Hall K, Hramiak I, Miller ME, Osei K, Simons-Morton DG; ACCORD Study Group.

    Am J Cardiol. 2007 Jun 18;99(12A):80i-89i. Epub 2007 Apr 17.PMID: 17599428 [PubMed - indexed for MEDLINE]Related articles

    23.

    Treatment models from the International Diabetes Center: advancing from oral agents to insulin therapy in type 2 diabetes.

    Bergenstal RM.

    Endocr Pract. 2006 Jan-Feb;12 Suppl 1:98-104.PMID: 16627391 [PubMed - indexed for MEDLINE]Related articles

    24.

    Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of control.

    Bergenstal RM, Nag SS, Reusch JE, Sajjan SG, Alexander CM.

    Endocr Pract. 2005 May-Jun;11(3):172-9.PMID: 16239203 [PubMed - indexed for MEDLINE]Related articles

    25.

    The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference.

    Bergenstal RM, Gavin JR 3rd; Global Consensus Conference on Glucose Monitoring Panel.

    Am J Med. 2005 Sep;118(Suppl 9A):1S-6S. Review.PMID: 16224936 [PubMed - indexed for MEDLINE]Related articles

    26.

    Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial.

    DeFronzo RA, Bergenstal RM, Cefalu WT, Pullman J, Lerman S, Bode BW, Phillips LS; Exubera Phase III Study Group.

    Diabetes Care. 2005 Aug;28(8):1922-8.PMID: 16043733 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control.

    Bergenstal RM, Anderson RL, Bina DM, Johnson ML, Davidson JL, Solarz-Johnson B, Kendall DM.

    Diabetes Technol Ther. 2005 Apr;7(2):241-7.PMID: 15857225 [PubMed - indexed for MEDLINE]Related articles

    28.

    Undetected, uncontrolled blood pressure in type 2 diabetes: self-monitored blood pressure profiles.

    Mazze RS, Robinson R, Simonson G, Idrogo M, Simpson B, Kendall D, Bergenstal R.

    Blood Press. 2004;13(6):335-42.PMID: 15771217 [PubMed - indexed for MEDLINE]Related articles

    29.

    Characterizing blood pressure control in individuals with Type 2 diabetes: the relationship between clinic and self-monitored blood pressure.

    Mazze RS, Simonson GD, Robinson RL, Kendall DM, Idrogo MA, Adlis SA, Boyce KS, Dunne CJ, Anderson RL, Bergenstal RM.

    Diabet Med. 2003 Sep;20(9):752-7.PMID: 12925057 [PubMed - indexed for MEDLINE]Related articles

    30.

    Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing.

    Bina DM, Anderson RL, Johnson ML, Bergenstal RM, Kendall DM.

    Diabetes Care. 2003 Apr;26(4):981-5.PMID: 12663560 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Identifying variables associated with inaccurate self-monitoring of blood glucose: proposed guidelines to improve accuracy.

    Bergenstal R, Pearson J, Cembrowski GS, Bina D, Davidson J, List S.

    Diabetes Educ. 2000 Nov-Dec;26(6):981-9.PMID: 11912810 [PubMed - indexed for MEDLINE]Related articles

    32.

    Comprehensive management of patients with type 2 diabetes: establishing priorities of care.

    Kendall DM, Bergenstal RM.

    Am J Manag Care. 2001 Aug;7(10 Suppl):S327-43; quiz S344-8. Review.PMID: 11519398 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Use of an automated device for alternative site blood glucose monitoring.

    Fineberg SE, Bergenstal RM, Bernstein RM, Laffel LM, Schwartz SL.

    Diabetes Care. 2001 Jul;24(7):1217-20.PMID: 11423505 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Optimization of insulin therapy in patients with type 2 diabetes.

    Bergenstal RM.

    Endocr Pract. 2000 Jan-Feb;6(1):93-7.PMID: 11419928 [PubMed - indexed for MEDLINE]Related articles

    35.

    A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

    Raskin P, Klaff L, Bergenstal R, Hallé JP, Donley D, Mecca T.

    Diabetes Care. 2000 Nov;23(11):1666-71.PMID: 11092290 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    The insulin sliding scale is not dead.

    Bergenstal RM, Fish LH, List S.

    Arch Intern Med. 1998 Feb 9;158(3):298. No abstract available. PMID: 9472213 [PubMed - indexed for MEDLINE]Related articles

    37.

    Cost-effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin-dependent diabetes mellitus.

    Franz MJ, Splett PL, Monk A, Barry B, McClain K, Weaver T, Upham P, Bergenstal R, Mazze RS.

    J Am Diet Assoc. 1995 Sep;95(9):1018-24.PMID: 7657903 [PubMed - indexed for MEDLINE]Related articles

    38.

    Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial.

    Franz MJ, Monk A, Barry B, McClain K, Weaver T, Cooper N, Upham P, Bergenstal R, Mazze RS.

    J Am Diet Assoc. 1995 Sep;95(9):1009-17.PMID: 7657902 [PubMed - indexed for MEDLINE]Related articles

    39.

    Intensified diabetes management: lessons from the diabetes control and complications trial.

    Mazze RS, Bergenstal R, Ginsberg B.

    Int J Clin Pharmacol Ther. 1995 Jan;33(1):43-51. Review.PMID: 7711992 [PubMed - indexed for MEDLINE]Related articles

    40.

    A joint venture with the commonwealth of independent states.

    Etzwiler D, Bergenstal R, Mazze R, Franz M, Haig B, Birk R, Neimann D, Henry W.

    Diabetes Care. 1993 Jan;16(1):394-7. No abstract available. PMID: 8422822 [PubMed - indexed for MEDLINE]Related articles

    41.

    Practice guidelines for nutrition care by dietetics practitioners for outpatients with non-insulin-dependent diabetes mellitus: methodologies for field-testing and cost-effectiveness analysis.

    Mazze RS, Franz MJ, Monk A, Cooper N, Barry B, Weaver T, McClain K, Upham P, Haugen D, Bergenstal R.

    J Am Diet Assoc. 1992 Sep;92(9):1139-42. No abstract available. PMID: 1512377 [PubMed - indexed for MEDLINE]Related articles

    42.

    Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapy.

    Bergenstal RM, Dupre J, Lawson PM, Rizza RA, Rubenstein AH.

    Diabetes. 1985 Aug;34 Suppl 3:31-6.PMID: 3926568 [PubMed - indexed for MEDLINE]Related articles

    43.

    Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII.

    Lawson P, Home PD, Bergenstal R.

    Diabetes. 1985 Aug;34 Suppl 3:27-30.PMID: 3894126 [PubMed - indexed for MEDLINE]Related articles

    44.

    Observations on control of glycemia with conventional insulin therapy or continuous subcutaneous insulin infusion.

    Tamborlane WV, Champion MC, Rizza RA, Service FJ, Bergenstal RM.

    Diabetes. 1985 Aug;34 Suppl 3:22-6.PMID: 3894125 [PubMed - indexed for MEDLINE]Related articles

    45.

    Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transport.

    Chang EB, Bergenstal RM, Field M.

    J Clin Invest. 1985 May;75(5):1666-70.PMID: 2987308 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Dietary practices of persons with diabetes during insulin pump therapy.

    Capper AF, Headen SW, Bergenstal RM.

    J Am Diet Assoc. 1985 Apr;85(4):445-9.PMID: 3980891 [PubMed - indexed for MEDLINE]Related articles

    47.

    Diabetic ketoacidosis. How to treat and, when possible, prevent.

    Bergenstal RM.

    Postgrad Med. 1985 Feb 1;77(2):151-7, 161.PMID: 2578658 [PubMed - indexed for MEDLINE]Related articles

    48.

    Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes.

    Polonsky KS, Herold KC, Gilden JL, Bergenstal RM, Fang VS, Moossa AR, Jaspan JB.

    Diabetes. 1984 Nov;33(11):1112-9.PMID: 6389228 [PubMed - indexed for MEDLINE]Related articles

    49.

    The effects of biosynthetic human proinsulin on carbohydrate metabolism.

    Revers RR, Henry R, Schmeiser L, Kolterman O, Cohen R, Bergenstal R, Polonsky K, Jaspan J, Rubenstein A, Frank B, et al.

    Diabetes. 1984 Aug;33(8):762-70.PMID: 6378699 [PubMed - indexed for MEDLINE]Related articles

    50.

    The metabolic effects of biosynthetic human proinsulin in individuals with type I diabetes.

    Bergenstal RM, Cohen RM, Lever E, Polonsky K, Jaspan J, Blix PM, Revers R, Olefsky JM, Kolterman O, Steiner K, et al.

    J Clin Endocrinol Metab. 1984 Jun;58(6):973-9.PMID: 6373814 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...